文献速递小儿神经外科与脑积水神经重症

体外出血性脑积水模型用于评估磁微执行器对抗分流管梗阻

Development of an In Vitro Hemorrhagic Hydrocephalus Model for Functional Evaluation of Magnetic Microactuators Against Shunt Obstructions.
PubMed 文献 · World Neurosurg · 2021-08-18

研究建立体外出血性脑积水模型,将磷酸盐缓冲液、血液和凝血酶驱动通过脑室腹腔分流管8小时,比较5根装有磁微执行器的脑室导管与5根对照导管。微执行器组梗阻更少、8小时引流量更大、颅内压>40 mm Hg时间更短且最大压力更低,提示其可能减少出血性脑积水患者的分流管梗阻。

要点

  • 磁微执行器可减少出血性脑积水体外模型中的分流管梗阻。
  • 微执行器组8小时引流量中位数256 mL,对照组30 mL。
  • 微执行器组颅内压>40 mm Hg总时间中位数0.0小时,对照组6.2小时。

核心结论

  • 磁微执行器除保护脑室导管外,还可能防止血肿阻塞阀门或远端导管,从而延长低颅内压持续时间。

研究设计与样本

  • 体外出血性脑积水模型,将磷酸盐缓冲液、血液和凝血酶驱动通过脑室腹腔分流管8小时。
  • 5根脑室导管装有微执行器,与5根对照导管比较,微执行器由外部磁场驱动30分钟。

主要发现

  • 对照组5根分流管发生6次梗阻(3次脑室导管、3次阀门-远端导管),微执行器组5根分流管发生1次梗阻(脑室导管)。
  • 对照组与微执行器组8小时引流量中位数分别为30 mL与256 mL。
  • 达到颅内压40 mm Hg的中位时间分别为13.8分钟与>8小时。
  • 颅内压>40 mm Hg的中位总时间分别为6.2小时与0.0小时。
  • 中位最大压力分别为192 mm Hg与36 mm Hg,微执行器组显著改善(P < 0.01)。

临床怎么用

  • 通过将患者头部置于外部磁场中激活微执行器,可能减少出血性脑积水患者的分流管梗阻。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Occlusion of ventriculoperitoneal shunts placed after intraventricular hemorrhage occurs frequently. The objective of this study was to develop a hemorrhagic hydrocephalus model to assess the ability of an oscillating microactuator within the ventricular catheter (VC) to prevent shunt obstruction. METHODS: An in vitro hydrocephalus model with extreme risk of shunt obstruction was created. Phosphate-buffered saline, blood, and thrombin were driven through ventriculoperitoneal shunts for 8 hours. Five VCs were fitted with a microactuator and compared with 5 control VCs. The microactuator was actuated by an external magnetic field for 30 minutes. Pressure within the imitation lateral ventricle was measured. RESULTS: In the 5 control shunts, 6 obstructions developed (3 VC, 3 valve-distal catheter) compared with 1 obstruction (VC) in the 5 microactuator shunts. In the control and microactuator groups, the median volume exiting the shunts in 8 hours was 30 mL versus 256 mL. Median time to reach an intraventricular pressure of 40 mm Hg (13.8 minutes vs. >8 hours), median total time >40 mm Hg (6.2 hours vs. 0.0 hours), and median maximum pressure (192 mm Hg vs. 36 mm Hg) were significantly improved in the microactuator group (P < 0.01). CONCLUSIONS: In addition to protecting the VC, the microactuator appeared to prevent hematoma obstructing the valve or distal catheter, resulting in a much longer duration of low intraventricular pressures. A microactuator activated by placing the patient's head in an external magnetic field could reduce shunt obstructions in hemorrhagic hydrocephalus.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Devathasan D, Bentley RT, Enriquez A, et al. Development of an In Vitro Hemorrhagic Hydrocephalus Model for Functional Evaluation of Magnetic Microactuators Against Shunt Obstructions. World Neurosurg. 2021. PMID: 34418611. doi:10.1016/j.wneu.2021.08.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。